The results demonstrated that genetic liability to type 2 diabetes was significantly associated with an elevated risk of 12 gastrointestinal conditions, including gastroesophageal reflux disease, gastric ulcer, acute gastritis, chronic gastritis, irritable bowel syndrome, diverticular disease, acute pancreatitis, cholelithiasis, cholelithiasis with cholecystitis, nonalcoholic fatty liver disease, liver cirrhosis, and ulcerative colitis [70]
GLP-1 medications include injectable forms such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), as well as oral semaglutide (Rybelsus)
Right treatment
Your provider reviews your medical history, lifestyle, and health goals to determine if a GLP-1 prescription is appropriate
The tirzepatide compound breaks down under heat stress, potentially resulting in reduced weight management effects even if the medication appears normal